---
title: "EPSTEIN NAVA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/9645f87f-5f21-5ade-aed2-bb4ac1e7040a
json: https://whiteintel.dev/api/public/dossier/9645f87f-5f21-5ade-aed2-bb4ac1e7040a
identifier: sec:0001466927
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# EPSTEIN NAVA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001466927`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/9645f87f-5f21-5ade-aed2-bb4ac1e7040a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9645f87f-5f21-5ade-aed2-bb4ac1e7040a  

## Ownership & control

### Holdings / subsidiaries

- **BIOCANCELL THERAPEUTICS INC.** (director) — https://whiteintel.dev/entity/a8dbc465-8648-5e6f-91b1-97c82ec4924a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **EPSTEIN NAVA**. Human view: https://whiteintel.dev/entity/9645f87f-5f21-5ade-aed2-bb4ac1e7040a · Structured JSON: https://whiteintel.dev/api/public/dossier/9645f87f-5f21-5ade-aed2-bb4ac1e7040a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._